| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V106454 | Anti-IGFBP2 Antibody (M14) | Anti-IGFBP2 antibody (M14) is a human anti-IGFBP2 monoclonal antibody inhibitor that binds to IGFBP2 with high affinity and blocks its binding to IGF1. | |
|
V117174 | AZD9362 | 1905412-80-7 | AZD9362 is a reversible, ATP-competitive, orally active insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor inhibitor. |
|
V117033 | BMS-577098 | 667402-44-0 | BMS-577098 is an orally effective ATP-competitive insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 value of 0.016 μM. |
|
V69510 | Chimaphilin | 482-70-2 | Chimaphilin is an IGF-1R inhibitor (IC50= 0.086 μM). |
|
V116765 | Cibrigirsen | 160614-28-8 | Cibrigirsen is an antisense oligonucleotide that targets the insulin-like growth factor I receptor (IGF-1R). |
|
|
V116859 | Cibrigirsen sodium | Cibrigirsen sodium is an antisense oligonucleotide that targets the insulin-like growth factor I receptor (IGF-1R). | |
|
V93052 | CL-A3-7 | 2763661-39-6 | CL-A3-7 is a virus-cell fusion inhibitor targeting RSV F protein. It works by blocking the interaction between the virus and the host IGF1R, effectively inhibiting the infection of wild-type and K394R mutant RSV. It is suitable for anti-RSV drug development and drug resistance research. |
|
V112671 | Cyclo (Gly-Pro) | 97011-16-0 | Gly-Pro is a cyclic dipeptide. |
|
V115251 | GTx-134 | 1008448-19-8 | GTx-134 is a dual insulin-like growth factor 1 receptor/insulin receptor (IGF-1R/IR) inhibitor with IC50 values of 97 nM for IGF-1R and 187 nM for IR. |
|
V69509 | IGF-1R inhibitor-2 | 1116236-15-7 | IGF-1R inhibitor-2 (example 121) is an inhibitor (blocker/antagonist) of the insulin-like growth factor-1 receptor (IGF-1R). |
|
V80351 | IGF-I (24-41) (TFA) (Insulin-like Growth Factor I (24-41) (TFA)) | IGF-I (24-41) (Insulin-like Growth Factor I (24-41)) TFA is the amino acid (AA) fragment 24 to 41 of insulin-like growth factor I. | |
|
V80352 | IGF-I (30-41) (TFA) (Insulin-like Growth Factor I (30-41) (TFA)) | IGF-I (30-41) (TFA) is the 30 to 41 amino acid (AA) fragment of insulin-like growth factor I. | |
|
V117523 | INSR Recombinant Human Active Protein Kinase | The entire IGF axis forms an interacting network consisting of peptide ligands IGF1, IGF2 and insulin, as well as receptors IGF1R, IGF2R and insulin receptor (INSR) (as an IGF-binding protein, IGFBP). | |
|
V69508 | Mecasermin (Human IGF-I; FK 780) | 68562-41-4 | Mecasermin (Human IGF-I; FK 780) is a recombinant human insulin-like growth factor I (IGF-I). |
|
V76719 | NBI-31772 hydrate | NBI-31772 hydrate is a potent inhibitor of the interaction between insulin-like growth factor IGF and IGFBP. | |
|
V69501 | Veligrotug (Veligrotug) | 2728655-31-8 | Veligrotug is an IgG1-kappa, anti-IGF1R (insulin-like growth factor 1 receptor, CD221) chimeric monoclonal antibody (mAb). |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
